Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-PDT for Papulopustular Rosacea
NCT02075671Phase 4Completed
- Sponsor
- George Washington University
- Start
- Apr 2014
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminolevulinic acid 10% gel in papulopustular rosacea, sponsored by George Washington University. Started Apr 2014; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02075671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075671.